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Phosphatidylinositol 4,5-bisphosphate (PIP2) is a versatile regulator of TRP channels.We report that inclusion of a PIP2 analogue, PIP2 1,2-dioctanoyl,
does not induce non-capacitative Ca2+ entry per se but enhanced Ca2+ entry stimulated either by thrombin or by selective depletion of the Ca2+ stores in
platelets, the dense tubular system, using 10 nMTG, and the acidic stores, using 20 μM2,5-di-(tert-butyl)-1,4-hydroquinone (TBHQ). Reduction of PIP2
levels by blocking PIP2 resynthesiswithLi
+ or introducing amonoclonal anti-PIP2 antibody, or sequestering PIP2 using poly-lysine, attenuatedCa
2+ entry
induced by thrombin, TG and TBHQ, and reduced thrombin-evoked, but not TG- or TBHQ-induced, Ca2+ release from the stores. Incubation with the
anti-hTRPC1 antibody did not alter the stimulation of Ca2+ entry by PIP2, whilst introduction of anti-hTRPC6 antibody directed towards the C-terminus
of hTRPC6 reduced Ca2+ and Mn2+ entry induced by thrombin, TG or TBHQ, and abolished the stimulation of Ca2+ entry by PIP2. The anti-hTRPC6
antibody, but not the anti-hTRPC1 antibody or PIP2, reduced non-capacitative Ca
2+ entry by the DAG analogue 1-oleoyl-2-acetyl-sn-glycerol. In
summary, hTRPC6 plays a role both in store-operated and in non-capacitative Ca2+ entry. PIP2 enhances store-operated Ca
2+ entry in human platelets,
most probably by stimulation of hTRPC6 channels.
© 2007 Elsevier B.V. All rights reserved.Keywords: Ca2+ influx; PIP2; Platelet; Thrombin; TG; TBHQ; hTRPC6; hTRPC11. Introduction
The transient receptor potential (TRP) proteins contain six
transmembrane domains and form cation-selective ion channels.
At present 29 vertebrate TRP isoforms have been recognized,
distributed among seven subfamilies (TRPC, TRPV, TRPM,
TRPML, TRPP, TRPA and TRPN) [1]. TRP channel subunits
have been shown to assemble into homo- or heterotetrameric
channel complexes. The subunit composition presumably influ-
ences the biophysical and regulatory properties of the resultingAbbreviations: BSA, bovine serum albumin; [Ca2+]c, cytosolic free calcium
concentration; DTS, dense tubular system; HBS, HEPES-buffered saline;
hTRPC1, human canonical transient receptor potential 1; hTRPC6, human
canonical transient receptor potential 6; IP3, inositol 1,4,5-trisphosphate; IP3R, IP3
receptor; PIP2, Phosphatidylinositol 4,5-bisphosphate; PMCA, plasma membrane
Ca2+ ATPase; TBHQ, 2,5-di-(tert-butyl)-1,4-hydroquinone; TG, thapsigargin
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cation channels are mammalian homologues of the photoreceptor
TRP channel inDrosophila melanogaster [3]. A number of recent
studies have provided evidence for the role of TRPC channels in
Ca2+ entry pathways, as well as for the different mechanisms of
regulation of channel gating [4–8]. TRPC channels has been
suggested to function as integrators of a number of intracellular
signals resulting from receptor-induced PLC activation, which
catalyzes the synthesis of inositol 1,4,5-trisphosphate (IP3) and
diacylglycerol (DAG) through the hydrolysis of phosphatidyli-
nositol 4,5-bisphosphate (PIP2) [9]. But, in addition to the role of
DAG on TRP channel function [10], its precursor, PIP2, has been
presented as a versatile regulator of TRP channels, which often
involves the interaction of the TRP subunits with the lipid itself,
independently of its hydrolysis products [11]. A number of TRP
channels are regulated by PIP2, including TRPV1, which has been
reported to be inhibited by PIP2 by interaction with a PIP2-binding
domain in the C-terminus of TRPV1, characterised by clusters of
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acids [12]. In contrast, several members of the TRPM family,
including TRPM4, 5, 7 and 8 are positively regulated by PIP2 and
under experimental conditions that prevent PIP2 resynthesis (by
phosphatidylinositol (PI) kinase inhibitors) or decrease PIP2 avail-
able (using PIP2 antibodies) these channels rundown or desensitise
[1,13,14]. In TRPM4 this regulation has been suggested to be
mediated by interaction with a putative PIP2-binding pleckstrin
homology (PH) domain located in the C-terminus [14].
Growing evidence suggests that TRPC channels are also
regulated by PIP2. TRPC3 complexed with PLCγ forms an
intermolecular PH domain, which shows a high affinity for PIP2
[9]. In addition, TRPC6 has been shown to be activated by
hydrolysis of PIP2 in neurones [15]. From the seven identified
members of the TRPC family (TRPC1 through TRPC7),
platelets have been shown to express TRPC1, TRPC3,
TRPC4, TRPC5 and TRPC6 [16–18]. TRPC1, TRPC4 and
TRPC5 have been shown to form a heteromultimer associated
with platelet lipid raft domains, whereas TRPC3 and TRPC6
also associate but, in this case, independently of lipid rafts [18].
TRPC1 and TRPC6 are putative store-operated Ca2+ channels
[5,6,19,20]. In addition TRPC6 has been suggested to be
involved in receptor-activated, diacylglycerol-mediated cation
entry [1,21]. We have previously shown that impairment of PIP2
resynthesis in platelets by inhibition of PI4 kinase results in
inhibition of store-operated Ca2+ entry (SOCE) [22]. Hence, we
have investigated the role of PIP2 in the regulation of TRPC1
and TRPC6 channel function in human platelets.
2. Materials and methods
2.1. Materials
Fura-2 acetoxymethyl ester (fura-2/AM) and calcein-AM were from
Molecular Probes (Leiden, The Netherlands). Apyrase (grade VII), aspirin,
thapsigargin (TG), thrombin, lithium chloride, poly-lysine and bovine serum
albumin (BSA) were from Sigma (Madrid, Spain). Ionomycin and 1-oleoyl-2-
acetyl-sn-glycerol (OAG) were from Calbiochem (Nottingham, UK). 2,5-di-
(tert-butyl)-1,4-hydroquinone (TBHQ) was from Alexis (Nottingham, UK).
N-(p-amylcinnamoyl)anthranilic acid was from BIOMOL Research Labora-
tories (Plymouth Meeting, PA, USA). Phosphatidylinositol 4,5-bisphosphate
(PIP2) (1,2-dioctanoyl) was from Scharlab (Barcelona, Spain). Monoclonal
anti-phosphatidylinositol 4,5-bisphosphate antibody (anti-PIP2) was from
Assay Design Inc (Ann Arbor, MI, USA). Anti-hTRPC1 polyclonal antibody
was from Alomone Laboratories (Jerusalem, Israel). Anti-hTRPC6 polyclonal
antibody and control antigen peptide were from Santa Cruz (Santa Cruz, CA,
USA). All other reagents were of analytical grade.
2.2. Platelet preparation
Fura-2-loaded platelets were prepared as previously described [23] as
approved by Local Ethical Committees and in accordance with the Declaration
of Helsinki. Briefly, blood was obtained from healthy drug-free volunteers and
mixed with one-sixth volume of acid/citrate dextrose anticoagulant containing
(in mM): 85 sodium citrate, 78 citric acid and 111 D-glucose. Platelet-rich
plasma (PRP) was then prepared by centrifugation for 5 min at 700×g and
aspirin (100 μM) and apyrase (40 μg/mL) were added. Platelet-rich plasma was
incubated at 37 °C with 2 μM fura-2 acetoxymethyl ester for 45 min. Cells were
then collected by centrifugation at 350×g for 20 min and resuspended in
HEPES-buffered saline (HBS), pH 7.45, containing (in mM): 145 NaCl, 10
HEPES, 10 D-glucose, 5 KCl, 1 MgSO4 and supplemented with 0.1% BSA and
40 μg/mL apyrase.2.3. Cell viability
Cell viability was assessed using calcein and trypan blue. For calcein loading,
cells were incubated for 30 min with 5 μM calcein-AM at 37 °C, centrifuged and
the pellet was resuspended in fresh HBS. Fluorescence was recorded from 2 mL
aliquots using a Cary Eclipse Spectrophotometer (Varian Ltd., Madrid, Spain).
Samples were excited at 494 nm and the resulting fluorescence was measured at
535 nm. The results obtained with calcein were confirmed using the trypan blue
exclusion technique. 95% of cells were viable in our platelet preparations, at least
during the performance of the experiments.
2.4. Measurement of cytosolic free calcium concentration ([Ca2+]c )
Fluorescence was recorded from 2 mL aliquots of magnetically stirred platelet
suspension (2×108 cells/mL) at 37 °Cusing a fluorescence spectrophotometerwith
excitation wavelengths of 340 and 380 nm and emission at 505 nm. Changes in
[Ca2+]c were monitored using the fura-2 340/380 fluorescence ratio and calibrated
according to the method of Grynkiewicz and coworkers [24]. Mn2+ influx was
monitored as a quenching of fura-2 fluorescence at the isoemissive wavelength of
360 nm, which is presented on an arbitrary linear scale [25].
Ca2+ entry was estimated using the integral of the rise in [Ca2+]c for 2.5min after
addition of CaCl2 [26]. Control experiments were performed for all experimental
procedures in order to correct Ca2+ entry by subtraction of the [Ca2+]c elevation due
to leakage of the indicator. Ca2+ release was estimated using the integral of the rise in
[Ca2+]c for 3 min after the addition of thrombin, TG or TBHQ. Both Ca
2+ entry and
release are expressed as nM.s, as previously described [27,28]. To calculate the initial
rate of Ca2+ elevation after the addition of Ca2+ to the medium, the traces were fitted
to the equation y=A×(1−e−KX) and to estimate the initial rate of fura-2 fluorescence
quenching after the addition of Mn2+ to the medium, the traces were fitted to the
equation y=S×e−KX+A, whereK is the slope, S is the span andA is the plateau [29].
To compare the rate of decay of [Ca2+]c to basal values after platelet stimulation
with TG plus ionomycin in the absence or presence of PIP2 we used the constant of
the exponential decay. Traces were fitted to the equation y=S×(1−e−K1T)×e−K2T,
as previously described [30], where K1 and K2 are the constants of the exponential
increase and decay, respectively, T is time and S is the span.
2.5. Reversible electroporation procedure
The platelet suspension was transferred to an electroporation chamber
containing antibodies at a final concentration of 2 μg/mL, and the antibodies
were transjected according to published methods [31–33]. Reversible electro-
permeabilization was performed at 4 kV/cm at a setting of 25-microfarad
capacitance and was achieved by 7 pulses using a Bio-Rad Gene Pulser Xcell
Electroporation System (Bio-Rad, Hercules, CA, USA). Following electropora-
tion, cells were incubated with antibodies for an additional 60 min at 37 °C then
were centrifuged at 350×g for 20 min and resuspended in HBS containing
200 μM CaCl2. At the time of experiment 250 μM EGTA was added.
2.6. Immunofluorescence
Samples of platelet suspension (200 μM; 108 cells/mL) were transferred to
200 μL of ice-cold 3% (w/v) formaldehyde in phosphate-buffered saline (PBS;
containing 137 mM NaCl, 2.7 mM KCl, 5.62 mM Na2HPO4, 1.09 mM
NaH2PO4, 1.47mMKH2PO4, pH 7.2, and supplementedwith 0.5% (w/v) bovine
serum albumin) for 10 min and then incubated for 1 h with 1 μg/mL anti-PIP2
antibody. The platelets were then collected by centrifugation and washed twice in
PBS. To detect the primary antibody, samples were incubated with 0.02 μg/mL
FITC-conjugated goat anti-mouse IgG antibody for 1 h andwashed twice in PBS.
Fluorescence was measured using a fluorescence spectrophotometer (Varian
Ltd., Madrid, Spain). Samples were excited at 496 nm, and emission was at
516 nm.
2.7. Statistical analysis
Analysis of statistical significance was performed using one-way analysis of
variance. For comparison between two groups Student's t test was used. pb0.05
was considered to be significant for a difference.
Fig. 2. PIP2 enhances TG-induced cation entry in human platelets. (A) Fura-2-
loaded human platelets were treated in a Ca2+-free medium (100 μM EGTAwas
added) with various concentrations of PIP2 1,2-dioctanoyl (1–10 μM) or the
vehicle (HBS) and 1 min later were stimulated with 10 nM TG followed by
addition of CaCl2 (final concentration 300 μM) to initiate Ca
2+ entry.
Modifications in [Ca2+]c were monitored using the 340/380 nm ratio and traces
were calibrated in terms of [Ca2+]c. (B) Human platelets were loaded with Fura-2
2+
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3.1. PIP2 enhances store-operated divalent cation entry in
human platelets
In the absence of extracellular Ca2+ (100 μM EGTA was
added), treatment of fura-2-loaded human platelets in stirred
cuvettes at 37 °C with 0.1 U/mL thrombin induced a transient
increase in [Ca2+]c. Subsequent addition of Ca
2+ to the
extracellular medium (300 μM) resulted in a rapid rise in [Ca2+]c
indicative of Ca2+ entry (Fig. 1, top panel). Treatment of platelets
with 1, 3 or 10 μM of the water-soluble PIP2 analogue, PIP2 1,2-
dioctanoyl, significantly increased thrombin-evokedCa2+ entry by
127±6%, 137±10% and 140±5%, respectively (Fig. 1, top panel;
mean±S.E.M.; one-way analysis of variance; pb0.05; n=5). The
initial slope for the rise in [Ca2+]c after the addition of Ca
2+ was
significantly enhanced from 0.0565±0.0065 to 0.0792±0.0067 in
control and PIP2 1,2-dioctanoyl (10μM)-treated cells, respectively
(pb0.05, Student's t test). Addition of PIP2 1,2-dioctanoyl before
thrombin reduced thrombin-evoked Ca2+ release from the intra-
cellular stores in a concentration-dependent manner (Ca2+ release
estimated as the integral of the rise in [Ca2+]c for 3 min after the
addition of thrombin in a Ca2+-free mediumwas 86±3%, 79±9%
and 64±9% of control at 1, 3 and 10 μM PIP2 1,2-dioctanoyl;
Fig. 1, top panel; pb0.05; n=5). As shown in Fig. 1, lower panel,
addition of 10 μM PIP2 1,2-dioctanoyl to the platelet suspension
has a negligible effect on cytosolic Ca2+ mobilization either in the
absence or presence of extracellular Ca2+, which strongly support
that PIP2 does not induce non-capacitative Ca
2+ entry in these
cells.Fig. 1. PIP2 increases thrombin-evoked Ca
2+ entry in human platelets. Top
panel, Fura-2-loaded human platelets were treated in a Ca2+-free medium
(100 μM EGTA was added) with various concentrations of the water-soluble
PIP2 analogue, PIP2 1,2-dioctanoyl (1–10 μM), or the vehicle (HBS) and 1 min
later were stimulated with 0.1 U/mL thrombin followed by addition of CaCl2
(final concentration 300 μM) to initiate Ca2+ entry. Bottom panel, cells were
treated in a Ca2+-free medium with 10 μM PIP2 1,2-dioctanoyl followed by the
addition of CaCl2 as above. Modifications in [Ca
2+]c were monitored using the
340/380 nm ratio and traces were calibrated in terms of [Ca2+]c. Traces are
representative of five separate experiments.
and resuspended in a Ca -free medium. Fura-2-fluorescence was measured
with an excitation wavelength of 360 nm, the isoemissive wavelength. Platelets
were treated in the absence or presence of 3 μM PIP2 1,2-dioctanoyl and 1 min
later cells were stimulated with 10 nM TG or DMSO (as control) followed by the
addition of MnCl2 (final concentration 300 μM). Mn
2+ was added to untreated
control cells (DMSO) or cells treated with TG in the absence (TG) or presence of
PIP2 (TG+PIP2). Traces are representative of six separate experiments.We have recently identified two mechanisms for SOCE in
human platelets regulated by two separate Ca2+ compartments:
the dense tubular system (DTS) and acidic stores [34]. The DTS
contains an isoform of SERCA that shows a high sensitivity to TG
and is insensitive to TBHQ; in contrast, the acidic organelles
express a TBHQ-sensitive SERCA isoform with low affinity for
TG [35–38]. Since thrombin is able to mobilise Ca2+ from both
stores [39], we have investigated the effect of PIP2 on SOCE
induced by low concentrations of TG (by depletion of the DTS) or
by TBHQ (to discharge the acidic stores) in platelets. As
previously reported [38,39], in the absence of extracellular Ca2+,
addition of TG (10 nM) to fura-2-loaded human platelets in stirred
cuvettes at 37 °C evoked a prolonged increase in [Ca2+]c due to
release of Ca2+ from the DTS. Subsequent addition of Ca2+
(300 μM) to the external medium induced a sustained increase in
[Ca2+]c indicative of SOCE (Fig. 2A). Treatment with 1, 3 or
10 μM PIP2 1,2-dioctanoyl, significantly enhanced Ca
2+ influx
induced by TG by 157±20%, 212±30% and 297±17%,
respectively (Fig. 2A; pb0.05; n=6). The initial slope for the
rise in [Ca2+]c after the addition of Ca
2+ was significantly
Fig. 3. PIP2 enhances TBHQ-induced cation entry in human platelets. (A) Fura-
2-loaded human platelets were treated in a Ca2+-free medium (100 μM EGTA
was added) with various concentrations of PIP2 1,2-dioctanoyl (1–10 μM) or the
vehicle (HBS) and 1 min later were stimulated with 20 μM TBHQ followed by
addition of CaCl2 (final concentration 300 μM) to initiate Ca
2+ entry.
Modifications in [Ca2+]c were monitored using the 340/380 nm ratio and traces
were calibrated in terms of [Ca2+]c. (B) Human platelets were loaded with Fura-2
and resuspended in a Ca2+-free medium. Fura-2-fluorescence was measured
with an excitation wavelength of 360 nm, the isoemissive wavelength. Platelets
were treated in the absence or presence of 3 μM PIP2 1,2-dioctanoyl and 1 min
later cells were stimulated with 20 μM TBHQ or DMSO (as control) followed
by the addition of MnCl2 (final concentration 300 μM). Mn
2+ was added to
untreated control cells (DMSO) or cells treated with TBHQ in the absence
(TBHQ) or presence of PIP2 (TBHQ+PIP2). Traces are representative of six
separate experiments.
Fig. 4. Effect of PIP2 on restoration of [Ca
2+]c in human platelets. Fura-2-loaded
human platelets were treated in a Ca2+-free medium (100 μM EGTAwas added)
with PIP2 1,2-dioctanoyl (3 μM; PIP2) or the vehicle (Control) and 1 min later
were stimulated with TG (1 μM) combined with ionomycin (50 nM). Elevations in
[Ca2+]i were monitored using the 340/380 nm ratio and traces were calibrated in
terms of [Ca2+]c. Traces shown are representative of five independent experiments.
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PIP2 1,2-dioctanoyl (10 μM)-treated cells, respectively (pb0.05).
Treatment with PIP2 1,2-dioctanoyl had no significant effects on
Ca2+ release from the intracellular store, indicating that accu-
mulation of Ca2+ in the DTS was unaffected by addition of PIP2
1,2-dioctanoyl (Fig. 2A; n=6).
Mn2+ was used to evaluate the effect of PIP2 on divalent cation
influx. This cation can be used as a surrogate for Ca2+ entry given
its quenching effect on fura-2 [25]. Fura-2 was excited at the
isoemissive wavelength, 360 nm, to allow monitoring of quench-
ing of fluorescence by Mn2+. Addition of Mn2+ (300 μM) to
platelets treatedwith TG resulted in a sustained quenching of fura-2
fluorescence (Fig. 2B, traces TG) compared with non-stimulated
cells (Fig. 2B, trace DMSO). Addition of 3 μM PIP2 1,2-
dioctanoyl before TG significantly increased the rate of Mn2+
entry. The initial slope for the rate of fura-2 fluorescence quenching
after the addition of Mn2+ were 0.0409±0.0021 and 0.0491±
0.0020 for control and PIP2 1,2-dioctanoyl-treated cells. These
results indicate that PIP2 enhances DTS-regulated divalent cation
entry.Our studies investigating the effect of PIP2 on SOCE stim-
ulated by TBHQ reported similar results. As shown in Fig. 3A,
in the absence of extracellular Ca2+, TBHQ (20 μM), which
fully depletes the acidic stores [34,38,39], induced a sustained
elevation in [Ca2+]c. Subsequent addition of Ca
2+ (300 μM)
induced a sustained increase in [Ca2+]c indicative of SOCE.
Addition of PIP2 1,2-dioctanoyl significantly enhanced TBHQ-
evoked Ca2+ influx by 131±19%, 150±10% and 179±14% at
the concentrations 1, 3 and 10 μM, respectively, without having
any effect on Ca2+ release from the stores (Fig. 3A; pb0.05;
n=6). The initial slope for the rise in [Ca2+]c after the addition
of Ca2+ was enhanced from 0.0525±0.0035 to 0.0732±0.0047
in control and PIP2 1,2-dioctanoyl (10 μM)-treated cells, re-
spectively ( pb0.05). In addition, PIP2 1,2-dioctanoyl (3 μM)
significantly enhanced the rate of Mn2+ entry induced by
TBHQ. The initial slope for the rate of fura-2 fluorescence
quenching after the addition of Mn2+ were 0.0329±0.0047 and
0.0451±0.0034 for control and PIP2 1,2-dioctanoyl-treated
cells. These findings indicate that PIP2 enhances divalent cation
entry induced by depletion of the acidic organelles in platelets.
3.2. PIP2 does not alter Ca
2+ extrusion
Established routes for Ca2+ extrusion are the Na+/Ca2+ ex-
changer and the plasma membrane Ca2+-ATPase (PMCA),
although in platelets the main mechanism for Ca2+ extrusion at
low [Ca2+]c has been reported to be the PMCA [30,40]. Using a
previously established procedure we have estimated Ca2+ extru-
sion in platelets as the rate of decay of [Ca2+]c to basal levels after
activation with 1 μM TG combined with a low concentration of
ionomycin (50 nM) to achieve extensive depletion of the internal
Ca2+ stores [30]. Treatment of platelets at 37 °C with 3 μM PIP2
1,2-dioctanoyl did not modify Ca2+ release from the intracellular
stores induced by TG plus ionomycin. In addition, PIP2 1,2-
dioctanoyl has a negligible effect on the rate of decay of [Ca2+]c to
basal levels. The decay constants were 0.0071±0.0005 and
0.0073±0.0006 in control and PIP2-treated platelets (Fig. 4; n=5).
Fig. 5. LiCl attenuatesCa2+ entry in human platelets. (A andB)Human platelets in PRPwere preincubated in the absence (A) or presence of 10mMLiCl (B) for 12 h, loaded
with fura-2 and resuspended in a Ca2+-free HBS. Cells were then stimulated with 0.1 U/mL thrombin followed by the addition of CaCl2 (final concentration 300 μM) to
initiate Ca2+ entry. (C and D) Platelets were preincubated with 10mMLiCl for 12 h, loaded with fura-2 and resuspended in a Ca2+-free HBS. Cells were treated with 20 μM
TBHQ followed by addition of 0.1 U/mL thrombin. 3 min later CaCl2 (final concentration 300 μM; C) or TG (1 μM) combined with ionomycin (50 nM; D) were added.
(E and F) Platelets were preincubated in the absence (Control) or presence of 10mMLiCl (Li+) for 12 h, as indicated, loadedwith fura-2 and resuspended in a Ca2+-freeHBS.
Cells were treated with 10 nM TG (E) or 20 μMTBHQ (F) followed by addition of CaCl2 (final concentration 300 μM) to initiate Ca
2+ entry. G, Platelets were incubated in
the absence and presence of poly-lysine (10 μg/mL, molecular weight ∼1000) for 1 h, as indicated, and then stimulated with 0.1 U/mL thrombin in a Ca2+-free medium
(100 μMEGTAwas added) followed by the addition of CaCl2 (final concentration 300 μM) to initiate Ca
2+ entry. Modifications in [Ca2+]c were monitored using the 340/
380 nm ratio and traces were calibrated in terms of [Ca2+]c. Traces are representative of six separate experiments.
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Fig. 6. Electrotransjection of anti-PIP2 antibody attenuates Ca
2+ entry. (A) Fixed human plateletswere incubatedwith either 1μg/mL anti-PIP2 antibody for 1 h (b), 0.02μg/mL
FITC-conjugated goat anti-mouse IgG antibody for 1 h (c) for 1 h with 1 μg/mL anti-PIP2 antibody followed by incubation with the FITC-conjugated anti rabbit IgG for a
further 1 h (d) or left untreated (a). In (e) cellswere treatedwith 10mMLiCl for 12 h and then incubated for 1 hwith 1μg/mLanti-PIP2 antibody followed by incubationwith the
FITC-conjugated anti rabbit IgG for a further 1 h. Histograms indicate the percentage of immunofluorescence under different experimental conditions relative to their control
(cells not treated with LiCl and incubated with both antibodies).Values are mean±S.E.M. of 4 independent experiments. (B–G) Human platelets (109 cells/mL) were
electropermeabilized in aGene Pulser as described inMaterials andmethods. Following electroporation, cells were incubated in the absence (B, D and F) or presence (C, E and
G) of 1μg/mL anti-PIP2 antibody for an additional 60min at 37 °C, loadedwith fura-2, centrifuged at 350×g for 20min and resuspended in HBS containing 200 μMCaCl2. At
the time of experiment 250 μMEGTAwas added. Fura-2-loaded human platelets were stimulated either with 0.1 U/mL thrombin (B and C), 10 nM TG (D and E) or 20 μM
TBHQ (F andG) and 4min later CaCl2, final concentration 300 μM,was added to themedium.Changes in fura-2 fluorescenceweremonitored using the 340-nm/380-nm ratio
and calibrated in terms of [Ca2+]c. Traces are representative of six independent experiments.
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Fig. 7. Effect of incubation with anti-hTRPC1 antibody on PIP2-induced increase in Ca
2+ entry. Fura-2-loaded human platelets were incubated for 30 min with
15 μg/mL of anti-hTRPC1 antibody (C and D) or the vehicle (A and B), as indicated. Cells were treated in a Ca2+-free medium with PIP2 1,2-dioctanoyl (3 μM;
B and D) or the vehicle (HBS; A and C) and then stimulated with thrombin (0.1 U/mL) followed by addition of CaCl2 (final concentration 300 μM) to initiate Ca
2+
entry. Modifications in [Ca2+]c were monitored using the 340/380 nm ratio and traces were calibrated in terms of [Ca
2+]c. Traces are representative of five separate
experiments.
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The role of PIP2 on SOCE in platelets was further inves-
tigated by blocking its resynthesis by incubating the PRP with
LiCl (10 mM) for 12 h. In cells preincubated with Li+, thrombin-
evoked Ca2+ release was significantly reduced by 78±6%
(Fig. 5B vs. A; n=6; pb0.001), which is likely due to both
inhibition of PIP2 resynthesis and IP3 production. We have
previously shown that thrombin induces Ca2+ release from the
DTS and the acidic stores by synthesis of the intracellular
messengers IP3 and NAADP, respectively [39]; therefore, Ca
2+
accumulated in the acidic stores is expected to be releasable by
thrombin independently of IP3 generation. To test this
possibility, the acidic stores in Li+-treated cells were depleted
by treatment with 20 μM TBHQ prior to the stimulation with
thrombin. As shown in Fig. 5C, treatment of Li+-pretreated cells
with TBHQ abolished thrombin-induced Ca2+ release, although
the subsequent addition of 1 μMTG plus 50 nM ionomycin was
able to release Ca2+ from the DTS (Fig. 5D). These findings
confirm that Li+ treatment was essentially inhibiting PIP2 re-
synthesis, inducing PIP2 depletion whilst leaving the Ca
2+ stores
intact.
Pretreatment of platelets with 10mMLi+ significantly reduced
thrombin-induced Ca2+ entry by 60±8% (Fig. 5B vs. 5A;
pb0.05; n=6). Under these conditions SOCE induced by 10 nMTG or 20 μM TBHQ was reduced by 67±6% and 61±5%,
respectively (Fig. 5E vs. 5F; pb0.05; n=6). Pretreatment with
Li+ has no significant effect onCa2+ release byTGor TBHQ from
the intracellular stores, which further supports that PIP2 is not
required for Ca2+ storage. Our results indicate that treatment of
platelets with 3 μM PIP2 1,2-dioctanoyl overcame the effect of
Li+ on thrombin-induced Ca2+ entry (in the presence of PIP2 1,2-
dioctanoyl thrombin-evoked Ca2+ entry in Li+-treated cells was
116% of control; data not shown).
Poly-lysine, which contains positively charged residues, has
also been used to inhibit the activity of PIP2-activated ion
channels [41,42]. As shown in Fig. 5G, incubation of platelets
with 10μg/mL poly-lysine significantly reduced thrombin-evoked
Ca2+ release and entry by 60% and 50%, respectively (pb0.05;
n=5).
3.4. Electrotransjection of monoclonal anti-PIP2 antibody
attenuates SOCE
In order to decrease the amount of PIP2 available platelets were
reversibly electroporated and incubated with monoclonal anti-
PIP2 antibody following a previously published procedure [33].
As shown in Fig. 6A, incubation of fixed, non-permeabilized
platelets in suspension with 1 μg/mL anti-PIP2 antibody followed
by detection using a FITC-conjugated secondary antibody
Fig. 8. Electrotransjection of anti-hTRPC6 antibody impairs PIP2-induced increase in Ca
2+ entry. (A) Human platelets were lysed and whole-cell lysate was analysed
by Western blotting using either anti-hTRPC6 antibody (lane 1) or anti-hTRPC6 antibody preincubated with the control antigen peptide (CAP; lane 2) as described in
Materials and methods. The position of hTRPC6 is indicated on the left. Positions of molecular-mass markers are shown on the right. These results are representative of
four independent experiments. (B–E) Human platelets (109 cells/mL) were electropermeabilized in a Gene Pulser as described in Materials and methods. Following
electroporation, cells were incubated in the absence (B and C) or presence of 1 μg/mL anti-hTRPC6 antibody (D and E) for an additional 60 min at 37 °C, loaded with
fura-2, centrifuged at 350×g for 20 min and resuspended in HBS containing 200 μMCaCl2. At the time of experiment 250 μMEGTAwas added. Platelets were treated
with PIP2 1,2-dioctanoyl (3 μM; C and E) or the vehicle (HBS; B and D). Cells were then stimulated with thrombin (0.1 U/mL) followed by addition of CaCl2 (final
concentration 300 μM) to initiate Ca2+ entry. (F and G) Cells were preincubated for 30 min with 10 μMN-(p-amylcinnamoyl)anthranilic acid (ACA) and then treated
in the absence (F) of presence of 3 μM PIP2 1,2-dioctanoyl (G). Cells were stimulated with thrombin (0.1 U/mL) followed by addition of CaCl2 (final concentration
300 μM) to initiate Ca2+ entry. Modifications in [Ca2+]c were monitored using the 340/380 nm ratio and traces were calibrated in terms of [Ca
2+]c. Traces are
representative of five separate experiments.
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plasma membrane (column d; n=4). The fluorescence observed
was not due to non-specific binding of the secondary antibody, as
demonstrated by the lower fluorescence detected in samples
incubated with this antibody alone (column c; n=4). The increase
in fluorescence detected after incubation with the anti-PIP2
antibody was almost completely prevented when cells were
preincubated with lithium to reduce PIP2 recycling, which con-
firms specificity of the antibody.Electrotransjection of cells with 1 μg/mL anti-PIP2 antibody
significantly reduced thrombin-evoked Ca2+ release by 41±7%,
which suggest that the antibody was effectively reducing the
availability of PIP2 to thrombin-activated PLC. In addition,
electrotransjection of the anti-PIP2 antibody attenuated Ca
2+ entry
evoked by the physiological agonist thrombin by 26±6%, as well
as SOCE-induced by selective depletion of the DTS or the acidic
stores by using 10 nM TG or 20 μM TBHQ, respectively (in the
presence of the antibody SOCE-induced by TG or TBHQ was
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pb0.05; n=6). Incubation of intact (non electroporated) platelets
with 1 μg/mL anti-PIP2 antibody was unable to reduce thrombin-
evoked Ca2+ entry (data not shown), which indicates that the
electroporation procedure was effective introducing the antibody
into the cells. As for Li+, electrotransjection of the anti-PIP2
antibody did not significantly modify Ca2+ release induced by TG
orTBHQ,which further confirms that PIP2 is not required forCa
2+
accumulation into the stores.
3.5. Incubation with anti-hTRPC1 antibody inhibits thrombin-
induced Ca2+ influx but not the effect of PIP2
We have previously reported that preincubation of human
platelets with an antibody directed towards the sequence 557–571
located in the pore-forming region results in a concentration-
dependent inhibition of Ca2+ and Mn2+ influx induced by TG
(200 nM), as well as reduced thrombin-evoked Ca2+ entry [5].
Here, we have investigated whether the effect of PIP2 could be
mediated through the hTRPC1 protein by testing the effect of PIP2
1,2-dioctanoyl on Ca2+ entry in cells preincubated with the anti-
hTRPC1 antibody. If this were the case, the enhancing effect of
PIP2 on thrombin-induced Ca
2+ influx might be expected to be
affected by blockade of hTRPC1 channel function with the
antibody. To assess this, human platelet suspensions were
incubated for 30 min with 15 μg/mL of anti-hTRPC1 antibody
followed by stimulation with 0.1 U/mL thrombin to activate Ca2+
entry. As shown in Fig. 7, incubation with the anti-hTRPC1
antibody significantly reduced thrombin-evoked Ca2+ entry by
47±7% (pb0.01; n=5). This effect was prevented when the
antibody was incubated previously for 1 h in the presence of the
control antigen peptide (15 μg/mL; data not shown). Incubation
with the anti-hTRPC1 antibody did not significantly modify the
ability of thrombin to release Ca2+ from the intracellular stores
(Fig. 7C vs. Fig. 7A). We have previously shown that incubation
with 15 μg/mL of a non-specific IgG was unable to block TG-
induced SOCE [5], which shows the specificity of the assay.
In cells preincubated with the anti-hTRPC1 antibody, addition
of 3 μM PIP2 1,2-dioctanoyl prior to thrombin stimulation
enhanced Ca2+ entry relative to its control in the presence of the
antibody by 132±7%. This effect was not found to be statistically
different from the increase induced by 3 μM PIP2 1,2-dioctanoyl
in cells not treated with the anti-hTRPC1 antibody (137±10% as
described in the first section of results). These findings indicatesFig. 9. Electrotransjection of anti-hTRPC6 antibody attenuates TG- and TBHQ-evoked cat
Pulser as described in Materials and methods. Following electroporation, cells were incub
60min at 37 °C, as indicated, loadedwith fura-2, centrifuged at 350×g for 20min and resu
was added. Plateletswere then stimulatedwith 10 nMTG(AandC) or 20μMTBHQ(Ban
300 μM) 4 min later to initiate Ca2+ or Mn2+ entry, respectively. For Ca2+ mobilisation, m
calibrated in terms of [Ca2+]c. Mn
2+ was added to untreated control cells (DMSO) or cells (
Mn2+ entry, fura-2-fluorescence was measured with an excitation wavelength of 360
electropermeabilized in aGene Pulser as described inMaterials andmethods. Following ele
antibody for an additional 60min at 37 °C, as indicated, loadedwith fura-2, centrifuged at 3
incubated for 30 min in the absence or presence of 15 μg/mL of anti-hTRPC1 antibody, a
stimulatedwith 10 nMTG (E), 20μMTBHQ(F) or 1μMTG+50 nM ionomycin (G) follo
in [Ca2+]c were monitored as described above. Traces are representative of five separate ethat blockade of the hTRPC1 protein was without effect on PIP2-
induced increase in Ca2+ entry.
3.6. Electrotransjection of anti-hTRPC6 antibody inhibits
thrombin-induced Ca2+ entry and the enhancing effect of PIP2
We tested for the presence of hTRPC6 in human platelet lysates
by SDS/PAGE and Western blotting using an anti-hTRPC6
antibody, specific for an epitope located in the C-terminus of
hTRPC6. Immunoblotting of platelet whole-cell lysates with the
anti-hTRPC6 antibody revealed the presence of hTRPC6 in these
cells (Fig. 8A, lane 1; n=4). Detection of hTRPC6 was abolished
when the anti-hTRPC6 antibody was previously incubated for 1 h
with a control antigen peptide, confirming the specificity of the
antibody. These data support the reported presence of hTRPC6 in
human platelets [17,43], as well as in the immature megakaryo-
cytic Dami cell line and mature megakaryocytes [17]. In platelets,
hTRPC6 has been shown to form heteromultimeric complexes
with hTRPC3 [18].
To investigate the regulation of hTRPC6 by PIP2 in platelets
we have induced functional knock down of hTRPC6 by
electrotransjection of cells with anti-hTRPC6 antibody, directed
towards an intracellular C-terminal sequence, following a
previously described procedure [31–33]. Here we show for the
first time that electrotransjection with 1 μg/mL hTRPC6
significantly reduced thrombin-evoked Ca2+ entry by 33±5%
(Fig. 8D vs. Fig. 8B; pb0.05; n=5), without significantly alter
Ca2+ release (the integral of the rise in [Ca2+]c for 3 min after the
addition of thrombin in the presence of the anti-hTRPC6
antibody was 106±7% of control; Fig. 8D vs. Fig. 8B).
Electrotransjection with 1 μg/mL non-specific IgG following the
protocol used for the anti-hTRPC6 antibody was without effect
on thrombin-induced Ca2+ mobilization, which shows the
specificity of the assay (data not shown). To assess whether
the effect of PIP2 is mediated by regulation of the hTRPC6
protein we explored the effect of PIP2 1,2-dioctanoyl on Ca
2+
entry in cells electrotransjected with the anti-hTRPC6 antibody.
As shown in Fig. 8, functional knock down of hTRPC6
abolished the enhancing effect of PIP2 1,2-dioctanoyl (3 μM) on
thrombin-evoked Ca2+ entry ( pb0.01; n=5). Thus, thrombin-
induced Ca2+ entry in cells electrotransjected with the anti-
hTRPC6 antibody was similar in the absence and presence of the
PIP2 analogue (Fig. 8D and E). This effect was prevented when
the antibody was incubated previously for 1 h in the presence ofion entry. (A–D)Human platelets (109 cells/mL)were electropermeabilized in aGene
ated in the absence or presence of 1 μg/mL anti-hTRPC6 antibody for an additional
spended in HBS containing 200 μMCaCl2. At the time of experiment 250 μMEGTA
dD) followed by addition ofCaCl2 (A andB) orMnCl2 (C andD) (final concentration
odifications in [Ca2+]c were monitored using the 340/380 nm ratio and traces were
electrotransjected or not with anti-hTRPC6 antibody) treated with TG or TBHQ. For
nm, the isoemissive wavelength. (E–G) Human platelets (109 cells/mL) were
ctroporation, cellswere incubated in the absence or presence of 1μg/mLanti-hTRPC6
50×g for 20min and resuspended in HBS containing 200 μMCaCl2. Cells were then
s indicated. At the time of experiment 250 μMEGTAwas added. Platelets were then
wed by addition of CaCl2 (final concentration 300μM) to initiateCa
2+ entry. Changes
xperiments.
Fig. 10. Electrotransjection of anti-hTRPC6 antibody attenuates OAG-evoked
non-capacitative entry. (A) Human platelets (109 cells/mL) were electropermea-
bilized in a Gene Pulser as described in Materials and methods. Following
electroporation, cells were incubated in the absence or presence of 1 μg/mL anti-
hTRPC6 antibody for an additional 60 min at 37 °C, as indicated, loaded with
fura-2, centrifuged at 350×g for 20 min and resuspended in HBS containing
200 μM CaCl2. At the time of experiment 1 mM CaCl2 was added. Platelets
were treated with 100 μM OAG. (B) Fura-2-loaded human platelets were
incubated for 30 min with 15 μg/mL of anti-hTRPC1 antibody (anti-hTRPC1
ab: OAG) or the vehicle (OAG and PIP2: OAG). Cells were treated in a medium
containing 1 mM Ca2+ with PIP2 1,2-dioctanoyl (3 μM; PIP2: OAG) or the
vehicle (HBS; OAG and anti-hTRPC1 ab: OAG) and then stimulated with
100 μM OAG. Changes in [Ca2+]c were monitored as described above. Traces
are representative of four separate experiments.
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findings strongly suggest that the enhancing effect of PIP2 on
Ca2+ entry involves a positive regulation of hTRPC6 in human
platelets. In support of this hypothesis we have also found that
treatment of platelets with N-(p-amylcinnamoyl)anthranilic
acid, which has been shown to directly block hTRPC6 channels
[44], significantly reduced thrombin-evoked Ca2+-entry by 30%
(Fig. 8F; pb0.01; n=5) and abolished the enhanced effect
induced by PIP2 (Fig. 8G vs. Fig. 8C).
3.7. Electrotransjection of anti-hTRPC6 antibody reduces
TG- and TBHQ-induced Ca2+ entry
We have further investigated the role of hTRPC6 in TG- and
TBHQ-evoked Ca2+ entry in human platelets. As shown in
Fig. 9A and C, electrotransjection of cells with anti-hTRPC6
antibody significantly reduced Ca2+ and Mn2+ entry induced by
treatment with 10 nM TG by 30±5% and 50±4% ( pb0.01;
n=5). Similar results were observed when platelets were
stimulated with 20 μM TBHQ. Electrotransjection of the anti-
hTRPC6 antibody significantly attenuated TBHQ-evoked Ca2+
andMn2+ entry by 33±5% and 45±6% (Fig. 9B and D; pb0.01;
n=5).
3.8. Relative roles of hTRPC1 and hTRPC6 in SOCE induced
by depletion of DTS or the acidic stores
We have investigated the relative roles of hTRPC6 and
hTRPC1 in SOCE induced by 10 nM TG (to deplete the DTS),
20 μM TBHQ (to discharge the acidic stores) or 1 μM TG in
combination with 50 nM ionomycin (to induce extensive
depletion of both stores). As shown in Fig. 9E–G, electro-
transjection of cells with anti-hTRPC6 antibody significantly
reduced Ca2+ entry induced by TG, TBHQ or TG+ionomycin by
35±1%, 24±4% and 28±5%, respectively (pb0.01; n=5).
Incubation with the anti-hTRPC1 antibody significantly attenu-
ated Ca2+ entry induced by TG, TBHQ or TG+ ionomycin by
42±3%, 25±4% and 38±4%, respectively ( pb0.01; n=5),
while impairment of hTRPC1 and hTRPC6 channel function
significantly inhibited Ca2+ entry induced by TG, TBHQ or TG+
ionomycin by 65±2%, 48 ±4% and 63±2%, respectively
(pb0.01; n=5).
3.9. Electrotransjection of anti-hTRPC6 antibody attenuates
OAG-evoked non-capacitative Ca2+ entry
We have further investigated the role of hTRPC6 in non-
capacitative Ca2+ entry induced by OAG, a DAG analogue.
Electrotransjection of cells with anti-hTRPC6 antibody signif-
icantly reduced Ca2+ entry induced by OAG by 70% (Fig. 10;
pb0.05; n=4). In contrast, neither incubation with anti-TRPC1
antibody nor treatment with PIP2 1,2-dioctanoyl altered OAG-
evoked Ca2+ entry in human platelets (Fig. 10; n=4). These
findings suggest that hTRPC6, but not hTRPC1, is involved in
non-capacitative Ca2+ entry induced by OAG. In addition, our
results indicate that PIP2 does not modify non-capacitative Ca
2+
entry supporting that the stimulation of Ca2+ influx by thrombinor store depletion by TG or TBHQ induced by PIP2 was specific
for SOCE.
4. Discussion
The nature of the mechanisms underlying store-operated Ca2+
entry represents one of the fundamental and still unanswered
questions in cellular Ca2+ homeostasis. Among other messengers
involved in the regulation of Ca2+ entry, PIP2 has been presented
as a candidate to positively or negatively modulate the function of
ion channels, which require binding of PIP2 for activation. Apart
from the Drosophila TRP and TRPL channels, recent evidence
has suggested that several members of the mammalian TRP
channels are regulated by PIP2. Among these channels TRPV1
has been shown to be activated by PIP2 depletion [45]. In
addition, TRPM family members are inactivated by PIP2
hydrolysis or incubation with PIP2 antibodies, suggesting that
PIP2 depletion might be a signal for channel inactivation [13,46].
The regulation of TRPC channels by PIP2 has also been
suggested. TRPC3 is retained in the plasma membrane through
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suggest that PIP2 and TRPC3 channels are involved in signal
microdomains.
Using a water-soluble PIP2 analogue, PIP2 1,2-dioctanoyl, we
have found that PIP2 does not induce Ca
2+ mobilization in non-
stimulated platelets nor increases OAG-induced non-capacitative
Ca2+ entry. However, PIP2 enhances Ca
2+ entry stimulated by the
physiological agonist thrombin, which has been shown to induce
Ca2+ influx into human platelets secondarily to the emptying of
intracellular Ca2+ stores [47], as well as divalent cation entry
induced by depletion of the DTS or the acidic organelles, the two
Ca2+ stores described in human platelets [38]. The effect induced
by PIP2 on Ca
2+ entry is not due to inhibition of the ability of
platelets to remove Ca2+ from the cytosol since it has a negligible
effect, if any, in the restoration of [Ca2+]c to low resting levels
when a rise in [Ca2+]c was induced by depletion of the
intracellular Ca2+ stores using the SERCA inhibitor, TG, and a
low concentration of ionomycin. Our results indicate that PIP2
does not alter Ca2+ accumulation into the stores but reduces the
ability of thrombin to mobilise Ca2+ from the intracellular Ca2+
pools. This phenomenon might be attributed to the constitutive
inhibition of the IP3 receptors by direct interaction with PIP2.
Studies in rat cerebellum have reported that IP3 receptors forms a
stable inhibitory complex with endogenous PIP2 so that
disruption of IP3 receptor (IP3R)-PIP2 interaction by specific
anti-PIP2 antibodies resulted in 3–4-fold increase in IP3R activity
and apparent affinity for IP3. In support of this, exogenously
added PIP2 or the water-soluble analogue PIP2 1,2-dioctanoyl,
block IP3 binding to IP3R and inhibits IP3R activity [48]. This
interaction explains the inhibitory effect of PIP2 1,2-dioctanoyl on
thrombin-induced release of Ca2+ from the intracellular stores.
Addition of exogenous PIP2 under our conditions might attenuate
PIP2 depletion once PLC has been activated by thrombin, and a
number of IP3 receptors might still be blocked by PIP2.
To further support the involvement of PIP2 in Ca
2+ entry in
platelets we investigated the effect decreasing the levels of PIP2
either by PIP2 resynthesis blockade, using Li
+, a potent inhibitor
of the inositol monophosphatase that hydrolyses IP to inositol
[49], by introducing a monoclonal anti-PIP2 antibody, a procedure
that has been widely used to analyse the functional significance of
PIP2 [50–53] or by screening the PIP2 negatively charged head
groups using poly-lysine. As expected, these experimental pro-
cedures reduce the ability of thrombin to mobilise Ca2+ from the
intracellular stores, although they had no effect on Ca2+ storage by
the cells. In addition, these assays reduced Ca2+ entry induced by
thrombin or selective depletion of the DTS or the acidic stores.
Previous studies by us showing the inhibitory effect of Li+ on
SOCE were interpreted as a requirement of SOCE for basal levels
of IP3 to bind the IP3 receptors [16]. Now these results might be
interpreted as evidence for the requirement of PIP2 for the re-
gulation of cation channel function. In fact, xestospongin C, an IP3
receptor antagonist that blocks IP3-induced Ca
2+ release without
interacting with the IP3-binding site [54], was able to inhibit TG-
induced SOCE in platelets [16], which suggest a role for the IP3
receptor but not for IP3 binding in the activation of SOCE.
We have previously shown that hTRPC1 is involved in the
conduction of cation entry during the activation of SOCE inhuman platelets [5,55]. In addition, here we provide evidence
for the functional relevance of hTRPC6 in Ca2+ and Mn2+ entry
induced by thrombin or depletion of both Ca2+ stores, the DTS
and the acidic stores. Using specific antibodies for hTRPC1 and
6 proteins we have found that both proteins might be involved
in the formation of independent cation channels, since treatment
with these antibodies showed additive inhibitory effects on Ca2+
entry. Impairment of hTRPC6 but not of hTRPC1 function
prevented PIP2-induced increase in Ca
2+ entry, therefore
suggesting that PIP2 positively regulates hTRPC6.
PIP2 has also been shown to regulate TRPC6 in neurones,
although, in this case, the channel is activated by hydrolysis of
PIP2 [15]. The regulation of TRP channels by PIP2 might have a
remarkable effect in cellular Ca2+ homeostasis through the for-
mation ofmolecular complexes in signalmicrodomains involving
different proteins, such as PLC,which upon activation by receptor
occupation would decrease the level of PIP2, therefore activating
channels that are negatively regulated and inactivating channels
that are positively regulated by PIP2.
Taken together, our data and those of others suggest that
hTRPC6 might play a dual role in human platelets, as a non-
capacitative Ca2+ entry channel, regulated by DAG (or the
analogue OAG) as previously reported in platelets [43] and other
cells [56] and also as a component of the capacitative or store-
operated Ca2+ channels, which is likely regulated by cellular PIP2
levels. The latter is supported by several findings: (1) The lack of
effect of PIP2 per se on Ca
2+ mobilization both in the absence and
presence of extracellular Ca2+, which suggests that PIP2 does not
induce non-capacitative Ca2+ entry. (2) PIP2 induces stimulation
of Ca2+ entry mediated by the physiological agonist thrombin or
by selective depletion of the dense tubular system by 10 nM TG
and the acidic stores, using 20μMTBHQ.Considering the lack of
non-capacitative Ca2+ entry induced by PIP2 this effect is
expected to be mediated through the regulation of SOCE. We
cannot rule out the possibility that the increase in [Ca2+]c induced
by these agonists, specially thrombin, leads to the secretion of
platelet agonists that, in turn, might activate non-capacitativeCa2+
entry, although we have recently reported that the rise in [Ca2+]c
induced by 10 nMTGor 20μMTBHQ is unable per se to activate
platelet functions, such as aggregation, which would be expected
to be activated upon platelet agonist secretion [57]. In fact, rises in
[Ca2+]c induced by TG reaching over 400 μM, higher than those
induced by 10 nMTGeven in the presence of extracellularCa2+ in
our experiments, have been shown to be unable to activate platelet
ATP secretion [58]. (3) Stimulation of thrombin-, TG-, and
TBHQ-evoked divalent cation entry by PIP2 is impaired by
electrotransjection of anti-hTRPC6 antibody, which suggests a
role for hTRPC6 in PIP2-mediated effect, and (4) electrotransjec-
tion of anti-hTRPC6 antibody impaired divalent cation entry
induced by TG and TBHQ, which suggest a role for hTRPC6 in
SOCE.
As reported for other TRP proteins [12,14], PIP2 might
regulate hTRPC6 channel function by interaction with the C-
terminal domain, which is the region where the epitope recog-
nised by the anti-hTRPC6 antibody used is located. Different
mechanisms have been proposed to account for the potentiation
of TRP channel activity by PIP2, including that PIP2 interaction
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an open channel configuration. In addition, PIP2 might disrupt
the interaction between the channel and an inhibitory
molecule [59].
We hypothesize that activation of PLC-coupled receptors
plays a dual effect on hTRPC6 channel activity. First of all, PLC
activation leads to IP3 production, which releases Ca
2+ from
intracellular stores, leading to the activation of SOCE through
hTRPC6 and other channels, a process that is positively reg-
ulated by PIP2. On the other hand, PLC-dependent hydrolysis of
PIP2 evokes desensitization of hTRPC6, thereby limiting its
activity as described for other PIP2-regulated TRP channels
[14]. PIP2 might therefore be considered a useful tool to ex-
amine the role of TRPC6 in these cells. Although speculative,
the transient activation of hTRPC6 might be involved in the
initial steps of activation of SOCE in platelets, where two
functionally early and late phases have been reported [60].
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